These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 14135439)

  • 21. [COMPARATIVE STUDY OF TRYPTAMINE BLOCKING AGENTS].
    BUENO JR; KURTZ GS; SOLLERO L
    Hospital (Rio J); 1964 May; 65():1051-61. PubMed ID: 14172173
    [No Abstract]   [Full Text] [Related]  

  • 22. [PHARMACODYNAMIC ANTAGONISM BETWEEN 1-METHYL DERIVATIVE OF LYSERGIC ACID (DESERIL) AND 5-HYDROXYTRYPTAMINE (SEROTONIN) AND THEIR POSSIBLE REFLECTIONS IN OBSTETRIC THERAPY].
    MORLUNGHI C
    Minerva Ginecol; 1964 Nov; 16():938-41. PubMed ID: 14258966
    [No Abstract]   [Full Text] [Related]  

  • 23. METHYSERGIDE (SANSERT) IN THE PREVENTION OF MIGRAINE: A CLINICAL TRIAL.
    LLOYD-SMITH DL; MCNAUGHTON FL
    Can Med Assoc J; 1963 Dec; 89(24):1221-3. PubMed ID: 14084702
    [TBL] [Abstract][Full Text] [Related]  

  • 24. D-lysergic acid in the treatment of the biological features of childhood schizophrenia.
    Bender L
    Dis Nerv Syst; 1966 Jul; 7 Suppl(7):43-6. PubMed ID: 5965284
    [No Abstract]   [Full Text] [Related]  

  • 25. Serotonergic and dopaminergic distinctions in the behavioral pharmacology of (±)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) and lysergic acid diethylamide (LSD).
    Schindler EA; Dave KD; Smolock EM; Aloyo VJ; Harvey JA
    Pharmacol Biochem Behav; 2012 Mar; 101(1):69-76. PubMed ID: 22197710
    [TBL] [Abstract][Full Text] [Related]  

  • 26. EVALUATION OF ANTISEROTONIN AGENTS IN THE TREATMENT OF SEASONAL DERMATITIS IN DOGS.
    BAKER E
    Vet Med Small Anim Clin; 1965 Jul; 60():723-5. PubMed ID: 14301297
    [No Abstract]   [Full Text] [Related]  

  • 27. INCREASE IN ANTI-5HT ACTIVITY BY L-METHYLATION OF CLAVINE-TYPE ERGOT ALKALOIDS.
    YUI T; TAKEO Y
    Jpn J Pharmacol; 1964 Mar; 14():107-8. PubMed ID: 14167727
    [No Abstract]   [Full Text] [Related]  

  • 28. A NEW, POTENT AND SPECIFIC SEROTONIN INHIBITOR, (SQ 10,643) 2'-(3-DIMETHYLAMINOPROPYLTHIO) CINNAMANILIDE HYDROCHLORIDE: ANTISEROTONIN ACTIVITY ON UTERUS AND ON GASTROINTESTINAL, VASCULAR, AND RESPIRATORY SYSTEMS OF ANIMALS.
    RUBIN B; PIALA JJ; BURKE JC; CRAVER BN
    Arch Int Pharmacodyn Ther; 1964 Nov; 152():132-43. PubMed ID: 14248340
    [No Abstract]   [Full Text] [Related]  

  • 29. Dual actions of lysergic acid diethylamide tartrate (LSD), 2-bromo-D-lysergic acid diethylamide bitartrate (BOL) and methysergide on dorsal root potentials evoked by stimulation of raphe nuclei.
    Larson AA; Chinn C; Proudfit HK; Anderson EG
    J Pharmacol Exp Ther; 1981 Apr; 217(1):99-104. PubMed ID: 6110778
    [TBL] [Abstract][Full Text] [Related]  

  • 30. INSTRUMENTAL REWARD DISCRIMINATION IN RABBITS. ELECTROENCEPHALOGRAPHIC AND BEHAVIORAL EFFECTS OF A SERIES OF LYSERGIC ACID DERIVATIVES.
    BARAN L; LONGO VG
    Acta Physiol Lat Am; 1964; 14():125-37. PubMed ID: 14185502
    [No Abstract]   [Full Text] [Related]  

  • 31. [ANTI-SEROTONIN ACTION AND OTHER PHARMACOLOGICAL EFFECTS OF SOME ANALOGUES OF NATURAL ERGOT ALKALOIDS].
    VOTAVA Z; LAMPLOVA I
    Therapie; 1964; 19():733-42. PubMed ID: 14182956
    [No Abstract]   [Full Text] [Related]  

  • 32. THE EFFECTS OF DRUGS ON THE UPTAKE OF AMINES BY MAST CELLS.
    DAY M; STOCKBRIDGE A
    Br J Pharmacol Chemother; 1964 Oct; 23(2):405-19. PubMed ID: 14228141
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The acute effects of monoamine reuptake inhibitors on the stimulus effects of hallucinogens.
    Winter JC; Helsley S; Fiorella D; Rabin RA
    Pharmacol Biochem Behav; 1999 Jul; 63(3):507-13. PubMed ID: 10418794
    [TBL] [Abstract][Full Text] [Related]  

  • 34. USE OF METHYSERGIDE IN THE TREATMENT OF EXTRACRANIAL VASCULAR HEADACHE.
    LOVSHIN LL
    Headache; 1963 Oct; 3():107-11. PubMed ID: 14094106
    [No Abstract]   [Full Text] [Related]  

  • 35. Autistic schizophrenic children. An experiment in the use of d-lysergic acid diethylamide (LSD-25).
    FREEDMAN AM; EBIN EV; WILSON EA
    Arch Gen Psychiatry; 1962 Mar; 6():203-13. PubMed ID: 13894863
    [No Abstract]   [Full Text] [Related]  

  • 36. A NEUROPHARMACOLOGICAL INVESTIGATION ON HALLUCINOGENIC DRUGS. LABORATORY RESULTS VERSUS CLINICAL TRIALS.
    LONGO VG; BOVET D
    Acta Neurochir (Wien); 1964; 12():215-29. PubMed ID: 14293377
    [No Abstract]   [Full Text] [Related]  

  • 37. Prophylactic and therapeutic properties of 1-methyl-lysergic acid butanolamide in migraine.
    SICUTERI F
    Int Arch Allergy Appl Immunol; 1959; 15():300-7. PubMed ID: 14446408
    [No Abstract]   [Full Text] [Related]  

  • 38. METHYSERGIDE FOR PREVENTION OF HEADACHE; EXPERIENCE IN FIVE HUNDRED PATIENTS OVER THREE YEARS.
    GRAHAM JR
    N Engl J Med; 1964 Jan; 270():67-72. PubMed ID: 14063471
    [No Abstract]   [Full Text] [Related]  

  • 39. A FURTHER STUDY ON ALLEVIATION OF THE PSYCHOLOGICAL EFFECTS OF LSD IN MAN BY PRETREATMENT WITH 5-HYDROXYTRYPTOPHAN.
    PARE CM; LABROSSE EH
    J Psychiatr Res; 1963 Dec; 1():271-7. PubMed ID: 14101007
    [No Abstract]   [Full Text] [Related]  

  • 40. [EFFECT OF LYSENYL, DESERIL AND OTHER SEROTONIN ANTAGONISTS ON BIOCHEMICAL SYSTEMS].
    RYSANEK K; VITEK V
    Act Nerv Super (Praha); 1963 May; 5():210-1. PubMed ID: 14070658
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.